S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company

Microbot Medical (MBOT) Competitors

$1.25
+0.03 (+2.46%)
(As of 12/8/2023 ET)
Compare
Today's Range
$1.21
$1.25
50-Day Range
$1.13
$1.50
52-Week Range
$1.00
$4.39
Volume
30,800 shs
Average Volume
53,694 shs
Market Capitalization
$14.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

MBOT vs. SSKN, UTRS, OSA, ICU, TTOO, MDAI, VAPO, NXGL, FEMY, and VERO

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include STRATA Skin Sciences (SSKN), Minerva Surgical (UTRS), ProSomnus (OSA), SeaStar Medical (ICU), T2 Biosystems (TTOO), Spectral AI (MDAI), Vapotherm (VAPO), NEXGEL (NXGL), Femasys (FEMY), and Venus Concept (VERO). These companies are all part of the "surgical & medical instruments" industry.

Microbot Medical vs.

STRATA Skin Sciences (NASDAQ:SSKN) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.

Microbot Medical has a net margin of 0.00% compared to Microbot Medical's net margin of -20.40%. Microbot Medical's return on equity of -38.76% beat STRATA Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
STRATA Skin Sciences-20.40% -38.76% -14.12%
Microbot Medical N/A -146.17%-119.20%

STRATA Skin Sciences presently has a consensus target price of $3.80, indicating a potential upside of 590.41%. Microbot Medical has a consensus target price of $8.00, indicating a potential upside of 540.00%. Given Microbot Medical's higher possible upside, research analysts plainly believe STRATA Skin Sciences is more favorable than Microbot Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STRATA Skin Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, STRATA Skin Sciences and STRATA Skin Sciences both had 2 articles in the media. Microbot Medical's average media sentiment score of 1.43 beat STRATA Skin Sciences' score of 0.63 indicating that STRATA Skin Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STRATA Skin Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Microbot Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STRATA Skin Sciences has higher revenue and earnings than Microbot Medical. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STRATA Skin Sciences$36.16M0.53-$5.55M-$0.20-2.75
Microbot MedicalN/AN/A-$13.17M-$1.48-0.84

Microbot Medical received 122 more outperform votes than STRATA Skin Sciences when rated by MarketBeat users. Likewise, 70.55% of users gave Microbot Medical an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.

CompanyUnderperformOutperform
STRATA Skin SciencesOutperform Votes
223
63.90%
Underperform Votes
126
36.10%
Microbot MedicalOutperform Votes
345
70.55%
Underperform Votes
144
29.45%

STRATA Skin Sciences has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 3.14, meaning that its stock price is 214% more volatile than the S&P 500.

47.5% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 15.2% of Microbot Medical shares are owned by institutional investors. 40.4% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 10.6% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

STRATA Skin Sciences beats Microbot Medical on 9 of the 15 factors compared between the two stocks.


Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$14.64M$3.50B$4.50B$6.80B
Dividend YieldN/A3.90%2.94%4.56%
P/E Ratio-0.8416.5084.1811.99
Price / SalesN/A49.002,654.06110.25
Price / CashN/A49.6883.19124.94
Price / Book0.623.324.064.66
Net Income-$13.17M$57.42M$123.41M$177.35M
7 Day Performance-3.10%0.55%1.11%0.77%
1 Month Performance-9.42%24.11%10.45%9.24%
1 Year Performance-70.10%-14.71%9.33%8.19%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
STRATA Skin Sciences
2.1993 of 5 stars
$0.44
-4.3%
$3.80
+761.7%
-36.0%$15.46M$36.16M-2.20114Positive News
Gap Down
UTRS
Minerva Surgical
1.6852 of 5 stars
$1.64
-1.2%
$20.00
+1,119.5%
-40.0%$14.56M$50.29M-0.20174Positive News
OSA
ProSomnus
1.8056 of 5 stars
$0.82
-1.2%
$2.50
+203.1%
N/A$13.53M$19.39M0.00129News Coverage
Positive News
Gap Up
High Trading Volume
ICU
SeaStar Medical
2.4524 of 5 stars
$0.47
+6.8%
$5.00
+961.6%
-87.3%$17.42MN/A0.009Gap Up
TTOO
T2 Biosystems
0 of 5 stars
$3.70
-3.6%
N/A-97.5%$12.36M$22.31M0.00158Positive News
MDAI
Spectral AI
0 of 5 stars
$2.72
+8.8%
N/AN/A$18.45M$18.87M0.0080
VAPO
Vapotherm
0 of 5 stars
$3.25
+8.3%
N/A-82.1%$19.95M$67.60M-0.22261Positive News
High Trading Volume
NXGL
NEXGEL
1.9561 of 5 stars
$1.76
-5.4%
N/A+58.8%$10.07M$2.05M-3.6712News Coverage
Positive News
FEMY
Femasys
2.0926 of 5 stars
$1.01
-1.9%
$9.00
+791.1%
-17.7%$21.87M$1.21M-1.0434
VERO
Venus Concept
2.3939 of 5 stars
$1.58
-3.7%
$33.00
+1,988.6%
-72.0%$8.74M$99.50M-0.23384Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:MBOT) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -